homephotos Newsmarket Newsstocks NewsStocks to Watch: Axis Bank, Pidilite Industries, Indus Towers, Havells, JSW Energy and more

Stocks to Watch: Axis Bank, Pidilite Industries, Indus Towers, Havells, JSW Energy and more

SUMMARY

Stocks to Watch: From Axis Bank, Pidilite Industries, Indus Towers, Havells, United Spirits, Karnataka Bank to Sona BLW and more, here is a list of stocks to track in the trading session of January 24.

Profile image

By Jomy Jos Pullokaran  Jan 24, 2024 7:36:58 AM IST (Published)

Listen to the Article(6 Minutes)
3 Min Read
Axis Bank, stocks to watch, top stocks
Image count1 / 10

Axis Bank | Private sector lender reported a 3.7% year-on-year rise in net profit at ₹6,071.1 crore for the third quarter that ended December 31, 2023. Net interest income (NII) grew 9.4%, coming at ₹12,532 crore against ₹11,459.3 crore in the corresponding quarter of FY23.

Pidilite Industries, stocks to watch, top stocks
Image count2 / 10

Pidilite Industries | The company posted a 66% jump in its consolidated net profit at ₹510.92 crore in the December 2023 quarter. Its revenue from operations grew 4.41% to ₹3,130 crore during the quarter under review as against ₹2,997.59 crore a year ago. The company's total income rose 5.47% to ₹3,166.97 crore in the third quarter of FY23.

Indus Towers, stocks to watch, top stocks
Image count3 / 10

Indus Towers | Telecom infrastructure major reported a consolidated net profit of ₹1,540.1 crore for the third quarter that ended December 31, 2023. The company's consolidated revenue from operations increased 6.4% to ₹7,199 crore as against ₹6,765 crore in the corresponding period of the preceding fiscal.

Havells, stocks to watch, top stocks
Image count4 / 10

Havells | Homegrown consumer appliances major reported a 1.4% year-on-year rise in net profit at ₹287.9 crore for the third quarter that ended December 31, 2023. The company's revenue from operations increased 6.8% to ₹4,400.6 crore as against ₹4,119 crore in the corresponding period of the preceding fiscal.

United Spirits, stocks to watch, top stocks
Image count5 / 10

United Spirits | Diageo-controlled liquor maker reported a 63.5% year-on-year jump in net profit at ₹350.2 crore for the third quarter that ended December 31, 2023. The company's revenue from operations increased 8% to ₹3,002 crore as against ₹2,778.7 crore in the corresponding period of the preceding fiscal.

Karnataka Bank, stocks to watch, top stocks
Image count6 / 10

Karnataka Bank | Private sector lender reported a 10% rise in net profit to ₹331 crore for the third quarter ended December 2023. The bank had earned a net profit of ₹301 crore in the October-December quarter of 2022. The total income increased to ₹2,439 crore in the third quarter of the current fiscal compared to ₹2,055 crore in the year-ago period.

Sona BLW, stocks to watch, top stocks
Image count7 / 10

Sona BLW | Auto parts maker reported a 24% year-on-year rise in net profit at ₹113.6 crore for the third quarter that ended December 31, 2023. The company's revenue from operations jumped 15.8% to ₹781.8 crore against ₹675.3 crore in the corresponding period of the preceding fiscal.

Cyient DLM, stocks to watch, top stocks
Image count8 / 10

Cyient DLM | Electronic manufacturing services firm reported a 21.6% year-on-year rise in net profit at ₹6.2 crore for the third quarter that ended December 31, 2023. The company's revenue from operations increased 10% to ₹321 crore against ₹291.8 crore in the corresponding quarter driven by the aerospace and defence segment.

JSW Energy, stocks to watch, top stocks
Image count9 / 10

JSW Energy | The company reported over 28% rise in its consolidated net profit to ₹231 crore in the December 2023 quarter on the back of higher revenues. During the quarter, the total revenue increased 13% year-on-year to ₹2,661 crore from ₹2,350 crore in Q3 FY23, driven by incremental contributions from the renewable portfolio and strong thermal performance.

Lupin, stocks to watch, top stocks
Image count10 / 10

Lupin | Pharma major received tentative approval from the United States Food and Drug Administration (USFDA) for rivaroxaban tablets on January 23. The medicine, which has been tentatively approved by the USFDA, serves as a generic equivalent to Xarelto Tablets by Janssen Pharmaceuticals, Inc.

Check out our in-depth Market Coverage, Business News & get real-time Stock Market Updates on CNBC-TV18. Also, Watch our channels CNBC-TV18, CNBC Awaaz and CNBC Bajar Live on-the-go!
arrow down

Most Read

Share Market Live

View All
Top GainersTop Losers
CurrencyCommodities
CurrencyPriceChange%Change